Posted Jun. 9, 2014 at 10:40 a.m.

Premium Lock FDA approves Biogen Idec drug for bleeding disorder

Published: 2014-06-09 10:40:44
Updated: 2014-06-09 10:40:44

Biogen Idec Biogen

The U.S. Food and Drug Administration has approved Biogen Idec's Eloctate to treat patients with Hemophilia A. This is the second new drug approved for the company this year, and the third since the beginning of 2013....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll